Piper Sandler lowered the firm’s price target on Neogen to $17.50 from $24 and keeps a Neutral rating on the shares. The firm cites the company’s recent quarterly results.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NEOG:
